Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hormel Foods Corp (HRL) vs Nuwellis Inc (NUWE) Price & Performance

Hormel Foods CorpTrade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

Hormel Foods Corp vs Nuwellis Inc — how do they compare? Hormel Foods Corp trades at $19.48 (market cap $10.69B), while Nuwellis Inc trades at $0.68 (market cap $2.20M). The key difference: Hormel Foods Corp is far larger — about 4859.1× Nuwellis Inc's market cap, and Hormel Foods Corp pays a 6.02% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hormel Foods Corp for 99 Days and Nuwellis Inc for 26 Days on average.

HRLNUWE
Market Cap
$10.69B$2.20M
Volume
10,041,387121,544
Sector
Consumer StaplesHealth
52-Week High
$26.50$146.65
52-Week Low
$19.42$0.68
Typical Hold Time
99 Days26 Days
Enterprise Value
$12.67B-$1.52M
Dividend Yield
6.02%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hormel Foods Corp

Hormel Foods (HRL) trades at $19.55, down 1.66% on the day, with a bearish technical signal from moving averages. The company reported a net income margin of 2.82% for 2025, with recent quarterly EPS beats but a year-over-year decline in net income. Its acquisition of Brakebush for $1.06 billion aims to expand its foodservice chicken business, while the dividend yield remains a key attraction as a Dividend King.

The stock presents a mixed outlook: analyst consensus targets $24.25 imply upside, but high P/E of 31.53 and shrinking profit margins pose valuation and growth concerns. Risks include execution on acquisitions and consumer spending pressures, yet the strong dividend history offers income stability.

Nuwellis Inc

NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.

The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HRL
41% Buy59% Sell
Avg holding period · 99 Days
NUWE
40% Buy60% Sell
Avg holding period · 26 Days

Top news

Latest headlines on both assets

About Hormel Foods Corp

Hormel Foods is a protein-focused branded food company. Its brands include its namesake Hormel, Spam, Jennie-O, Dinty Moore, Applegate, Wholly Guacamole, and Skippy. The vast majority of the company's revenue is U.S.-based: 64% U.S. retail, 28% U.S. food service, and 8% international. By product type, in fiscal 2021, 23% of revenue was shelf-stable foods, 18% was poultry (branded and commodity), 55% was other perishable food, and 3% was other, primarily nutritional products. The company holds the number-one market position in shelf-stable meat, shelf-stable ready meals, pepperoni, natural/organic deli meat, and guacamole and the number-two position in turkey, bacon, chilled ready meals, and peanut butter.

Read more on HRL →

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE →